cbdMD (YCBD) Notes Payables (2017 - 2023)

cbdMD (YCBD) reported Notes Payables of $2492.0 for Q3 2023, down 74.07% on a YoY basis from $9609.0 in Q3 2022, and down 39.73% sequentially from $4135.0 in Q2 2023.

cbdMD (YCBD) Notes Payables (2017 - 2023) Analysis & Trends

cbdMD (YCBD) has 7 years of Notes Payables data on file, last reported at $2492.0 in Q3 2023.

  • For the quarter ending Q3 2023, Notes Payables fell 74.07% year-over-year to $2492.0; the trailing twelve-month figure through Sep 2023 stood at $2492.0 (down 74.07% YoY), and the FY2023 full-year result was $2492.0, down 74.07% from the prior year.
  • Notes Payables fell to $2492.0 in Q3 2023, from $4135.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $279606.0 in Q4 2019 to a low of $2492.0 in Q3 2023.
  • A 5-year average of $58146.3 and a median of $56106.0 in 2020 frame the typical range for Notes Payables.
  • Across the five-year window, Notes Payables plunged 93.51% in 2019 and increased 6.89% in 2022, its largest moves.
  • Tracing YCBD's Notes Payables over 5 years: stood at $279606.0 in 2019, then tumbled by 79.77% to $56573.0 in 2020, then rose by 6.88% to $60468.0 in 2021, then plunged by 83.86% to $9758.0 in 2022, then plunged by 74.46% to $2492.0 in 2023.
  • Business Quant data shows YCBD's Notes Payables at $2492.0 in Q3 2023, $4135.0 in Q2 2023, and $7375.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 cbdMD 438,678.80 -2.95 Mn 3.00 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 2,492.00
Jun 30, 2023 4,135.00
Mar 31, 2023 7,375.00
Dec 31, 2022 9,758.00
Sep 30, 2022 9,609.00
Jun 30, 2022 9,461.00
Mar 31, 2022 61,483.00
Dec 31, 2021 60,468.00
Sep 30, 2021 59,470.00
Jun 30, 2021 58,488.00
Mar 31, 2021 57,522.00
Dec 31, 2020 56,573.00
Sep 30, 2020 55,639.00
Mar 31, 2020 163,858.00
Dec 31, 2019 279,606.00
Jun 30, 2019 34,404.00
Dec 31, 2018 580,000.00
Sep 30, 2018 7,860.00
Jun 30, 2018 529,779.00
Dec 31, 2017 8,199.00